Literature DB >> 17318412

PAX6 increases glioma cell susceptibility to detachment and oxidative stress.

Jason Y Chang1, Yuanjie Hu, Eric Siegel, Latarsha Stanley, Yi-Hong Zhou.   

Abstract

PURPOSE: Glioblastoma multiforme (GBM) is an incurable malignant glioma which is very resistant to radiation and alkylating agent-based chemotherapy. Necrosis is a hallmark for GBM and the layer surrounding necrotic area is packed with cells which are now believed to be those migrating out of the necrotic area. Oxidative stress is a condition that GBM cells encounter in the necrotic zone, which is one of the stressful conditions that GBM cells need to resist in order to survive. Our previous studies revealed that low PAX6 expression is a favorable molecular trait for survival acquired by GBM cells because PAX6 could suppress cell invasion and tumorigenicity. Since detachment of cells from GBM is an early event for cell migration and subsequent invasion, we examined whether PAX6 is involved in cell survival after detachment. EXPERIMENTAL
DESIGN: PAX6 over-expression was achieved in glioma cells transiently (by adenoviral-mediated transient over-expression) or stably (by the establishment of stable cell lines after transfection). The effect of PAX6 over-expression on the survival and growth of glioma cells after detachment from the culture was determined. RESULT: Our data revealed that GBM cells (with their low PAX6 levels) survived the detachment procedure well. However, PAX6 over-expression attenuated GBM cell recovery of growth after detachment-induced stress. Importantly, intracellular reactive oxygen species (ROS) levels increased following cell detachment and that PAX6 over-expressing cells retained higher level of ROS than control cells. This may be partially responsible for the impaired growth rate after cell detachment. Addition of anti-oxidant improved the cell viability of PAX6 over-expressing cells, but did not restore their ability to proliferate.
CONCLUSION: To survive, GBM cells must resist oxidative stress in the necrotic zone as well as the intracellular ROS generated during detachment. Since PAX6 over-expression in low PAX6-expressing glioma cells attenuated cell survival and growth after detachment, these results suggest that a reduced PAX6 expression may be a molecular trait that gives glioma cells a real selection advantage over other cell types to survive in stressful conditions, thus resulting in expansion of their population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318412     DOI: 10.1007/s11060-007-9347-x

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.506


  20 in total

Review 1.  Nitric oxide and angiogenesis.

Authors:  M Ziche; L Morbidelli
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

2.  PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene.

Authors:  Debra A Mayes; Yuanjie Hu; Yue Teng; Eric Siegel; Xiaosong Wu; Kishori Panda; Fang Tan; W K Alfred Yung; Yi-Hong Zhou
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

3.  MR imaging correlates of survival in patients with high-grade gliomas.

Authors:  Whitney B Pope; James Sayre; Alla Perlina; J Pablo Villablanca; Paul S Mischel; Timothy F Cloughesy
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

4.  PAX6 suppresses growth of human glioblastoma cells.

Authors:  Yi-Hong Zhou; Xiaosong Wu; Fang Tan; Yue-Xi Shi; Tricia Glass; T J Liu; Kyle Wathen; Kenneth R Hess; Joy Gumin; Frederick Lang; W K Alfred Yung
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

5.  Oxidant stress and glioblastoma multiforme risk: serum antioxidants, gamma-glutamyl transpeptidase, and ferritin.

Authors:  J A Schwartzbaum; D G Cornwell
Journal:  Nutr Cancer       Date:  2000       Impact factor: 2.900

6.  The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group.

Authors:  R Sposto; I J Ertel; R D Jenkin; C P Boesel; J L Venes; J A Ortega; A E Evans; W Wara; D Hammond
Journal:  J Neurooncol       Date:  1989-07       Impact factor: 4.130

7.  The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival.

Authors:  Yi-Hong Zhou; Fang Tan; Kenneth R Hess; W K Alfred Yung
Journal:  Clin Cancer Res       Date:  2003-08-15       Impact factor: 12.531

8.  Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population.

Authors:  Daniel J Brat; Amilcar A Castellano-Sanchez; Stephen B Hunter; Marcia Pecot; Cynthia Cohen; Elizabeth H Hammond; Sarojini N Devi; Balveen Kaur; Erwin G Van Meir
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

9.  Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes.

Authors:  Sophie Godard; Gad Getz; Mauro Delorenzi; Pierre Farmer; Hiroyuki Kobayashi; Isabelle Desbaillets; Michimasa Nozaki; Annie-Claire Diserens; Marie-France Hamou; Pierre-Yves Dietrich; Luca Regli; Robert C Janzer; Philipp Bucher; Roger Stupp; Nicolas de Tribolet; Eytan Domany; Monika E Hegi
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

Review 10.  Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer.

Authors:  N S Brown; R Bicknell
Journal:  Breast Cancer Res       Date:  2001-07-23       Impact factor: 6.466

View more
  12 in total

1.  Level of hydrogen peroxide affects expression and sub-cellular localization of Pax6.

Authors:  Sachin Shukla; Rajnikant Mishra
Journal:  Mol Biol Rep       Date:  2018-05-16       Impact factor: 2.316

2.  Pax6 represses androgen receptor-mediated transactivation by inhibiting recruitment of the coactivator SPBP.

Authors:  Julianne Elvenes; Ernst Ivan Simon Thomassen; Sylvia Sagen Johnsen; Katrine Kaino; Eva Sjøttem; Terje Johansen
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

3.  EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartment.

Authors:  Yuanjie Hu; Peter Dion Pioli; Eric Siegel; Qinghua Zhang; Jodi Nelson; Abhishek Chaturbedi; Marlon S Mathews; Daniel I Ro; Selma Alkafeef; Nelson Hsu; Mark Hamamura; Liping Yu; Kenneth R Hess; Bruce J Tromberg; Mark E Linskey; Yi-Hong Zhou
Journal:  Mol Cancer       Date:  2011-09-28       Impact factor: 27.401

4.  PAX Genes in Cancer; Friends or Foes?

Authors:  Caiyun G Li; Michael R Eccles
Journal:  Front Genet       Date:  2012-01-31       Impact factor: 4.599

5.  Excess caffeine exposure impairs eye development during chick embryogenesis.

Authors:  Zheng-Lai Ma; Guang Wang; Xin Cheng; Manli Chuai; Hiroshi Kurihara; Kenneth Ka Ho Lee; Xuesong Yang
Journal:  J Cell Mol Med       Date:  2014-03-17       Impact factor: 5.310

6.  Transcription factor PAX6 as a novel prognostic factor and putative tumour suppressor in non-small cell lung cancer.

Authors:  Yury Kiselev; Sigve Andersen; Charles Johannessen; Bjørn Fjukstad; Karina Standahl Olsen; Helge Stenvold; Samer Al-Saad; Tom Donnem; Elin Richardsen; Roy M Bremnes; Lill-Tove Rasmussen Busund
Journal:  Sci Rep       Date:  2018-03-22       Impact factor: 4.379

Review 7.  Transcription Factors That Govern Development and Disease: An Achilles Heel in Cancer.

Authors:  Dhananjay Huilgol; Prabhadevi Venkataramani; Saikat Nandi; Sonali Bhattacharjee
Journal:  Genes (Basel)       Date:  2019-10-12       Impact factor: 4.096

Review 8.  Potential targets and treatments affect oxidative stress in gliomas: An overview of molecular mechanisms.

Authors:  Shiyu Liu; Lihua Dong; Weiyan Shi; Zhuangzhuang Zheng; Zijing Liu; Lingbin Meng; Ying Xin; Xin Jiang
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

9.  PAX6 suppression of glioma angiogenesis and the expression of vascular endothelial growth factor A.

Authors:  Yi-Hong Zhou; Yuanjie Hu; Debra Mayes; Eric Siegel; Jae G Kim; Marlon S Mathews; Nelson Hsu; Daniel Eskander; Ong Yu; Bruce J Tromberg; Mark E Linskey
Journal:  J Neurooncol       Date:  2009-07-19       Impact factor: 4.130

10.  Generation of a PAX6 knockout glioblastoma cell line with changes in cell cycle distribution and sensitivity to oxidative stress.

Authors:  Beate Hegge; Eva Sjøttem; Ingvild Mikkola
Journal:  BMC Cancer       Date:  2018-05-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.